Drugs.com FDA MedWatch AlertsOriginal article
Baxter Issues Voluntary Nationwide Recall of Cefazolin In Dextrose Injection, USP, 2g/100mL (20mg/mL) Due To Particulate Matter Found In Solution
RegulatoryCefazolin in Dextrose Injection, USP, 2g/100mL (20mg/mL)Negative
AI Analysis
Summary
Baxter International voluntarily recalled a lot of Cefazolin in Dextrose Injection due to particulate matter contamination. The recall affects Lot LD175708 with expiration date February 14, 2027.
Outcome Details
Voluntary nationwide recall of Lot LD175708, Exp 14-Feb 2027 due to particulate matter found in solution
Importance:5/10
Sentiment:
-0.80
product recallsafety issueparticulate mattermanufacturing quality
Related Companies
Read the original article
Published by Drugs.com FDA MedWatch Alerts on July 24, 2026 2:09 PM